Why is Aurubis stock sliding today?

Aurubis shares fell 4.9% as the Richmond, Virginia recycling facility ramp was pushed back by ~6 months: Phase 1 now targets completion in FY2026/27 and Phase 2 in FY2027/28. Despite Q3 FY2026 strength—pre-tax profit up ~160% YoY to €149M and revenue up 40% to €6.45B—analysts flagged the delayed U.S. timeline as the key negative, with Deutsche Bank reiterating Hold (trimmed PT to €177) and UBS staying Neutral (PT €160). Sell-off follows a sharp run-up from the 52-week low (€93.30), while broader European and U.S. moves were subdued (S&P 500 +0.1%).

Analysis

The market is reclassifying Aurubis from a simple cyclical beneficiary into an execution-risk story. The immediate damage is not the near-term P&L, which still looks strong, but the multiple: when a growth option gets pushed out by 6-12 months, the equity market typically re-rates it from forward EBITDA expansion to a lower-quality cash-flow name. That matters more here because the U.S. project was likely carrying a disproportionate share of the stock’s rerating thesis, so the selloff can persist even if commodity prices stay constructive.

Second-order, the delay reduces pressure on competing recyclers and smelters with existing North American capacity, who can continue to capture feedstock and contract flow without a new entrant compressing spreads. It also keeps the U.S. domestic recycled-copper supply picture tighter for longer, which is supportive for imported material and for companies exposed to copper concentrate rather than secondary feedstock. In other words, the competitive loss is not just about one plant being late; it is about deferring the start of a local processing node that would have changed bargaining power in scrap procurement.

The key catalyst path is over the next 1-3 months, when analysts will likely translate the delay into lower medium-term EBITDA and capex-return assumptions. The thesis is falsified if management can show credible permitting/equipment remediation plus a firm commissioning path, or if they offset the delay with higher run-rate margins elsewhere. Absent that, the stock is vulnerable to another leg lower as investors fade the story and rotate toward names with cleaner execution or direct copper beta.

Key Decisions for Investors

• Short AIAGY on any 3-5% relief rally over the next 1-2 weeks; thesis is continued multiple compression as Richmond slips out of the valuation window. Risk/reward is attractive if the market starts cutting FY26/27 expectations, but stop if management delivers a verified recovery schedule.
• Pair trade: long FCX or COPX vs short AIAGY for the next 1-3 months. This isolates copper beta while monetizing Aurubis-specific execution risk; the spread should work if the market continues to reward clean-operating miners over delayed growth projects.
• If borrow/liquidity is poor, use a 3-6 month put spread on AIAGY rather than outright short exposure. Target a move back toward the post-earnings gap fill; invalidate the trade on a credible commissioning update or a sharp analyst target reset higher.
• Watch for downward revisions to medium-term EBITDA/capex return assumptions in the next analyst round. If estimates hold despite the delay, the selloff may be overdone; if they come down, add to the short on confirmation.